Health Condition 1: N972- Female infertility of uterine origin
Conditions
Interventions
Intervention1: DHEA (Dehydroepiandrosterone): DHEA - 25 mg twice a day for 15 days if serum testosterone is less than 0.2 ng/ml .
Control Intervention1: Oral Placebo: PLACEBO appearing similar to the
Sponsors
CRAFT Hospital and Research Centre
Eligibility
Inclusion criteria
Inclusion criteria: INCLUSION CRITERIA 1.Women with age more than or equal to 35 years Or 2.women with AMH value less than 1.1 ng/ml or AFC less than 5 to 7 Whose serum testosterone less than 0.2 ng/ml
Exclusion criteria
Exclusion criteria: EXCLUSION CRITERIA Women with PCOS. Women with serum Testosterone �0.2 ng/ml women with BMI more than 30kg/mt2 Women with Congenital and untreated or acquired uterine abnormality. Women with Untreated hydrosalpinx. Women with Thrombophilia. Women with uncontrolled endocrine and heamatological dysfunction. PGTA embryos Those planning embryo transfer as per endometrial receptivity ERA Thin endometrium less than 8mm in index cycle. severe male factor infertility. Difficult embryo transfer. Cases where only poor quality embryos are available. Couple with genetic and chromosomal abnormality
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Ongoing pregnancy rate or Live birth rateTimepoint: After 20 weeks | — |
Secondary
| Measure | Time frame |
|---|---|
| b-HCG positive rate ,clinical pregnancy rate , miscarriage rate.Timepoint: 6 weeks, 20 weeks | — |
Countries
India
Contacts
Public ContactDr Noushin Abdul Majiyd
Craft Hospital And Research Centre
Outcome results
None listed